XML 35 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 28, 2020
Mar. 30, 2019
Dec. 28, 2019
Cash flows from operating activities:      
Net (loss) income $ (78,694) $ 34,466  
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:      
Depreciation of property, plant, and equipment 22,433 22,629  
Amortization of intangible assets 935 937  
Provisions for excess and obsolete inventory 26,596 531  
Inventory, Firm Purchase Commitment, Loss (22,837) (52)  
Goodwill impairment 17,742 0  
Intangible asset impairments 26,500 0  
Other asset impairments and loss on disposal of property, plant and equipment, net of recoveries 2,050 433  
Amortization of debt issuance costs 353 367  
Stock-based compensation expense 1,945 4,613  
Unrealized foreign currency exchange loss (gain), net 3,856 (210)  
Provisions for (recoveries of) doubtful accounts receivable from customers 4,270 (2,562)  
Loss on extinguishment of debt 0 7,823  
Deferred income taxes (benefit) expense (10,053) 3,242  
Effect of changes in operating assets and liabilities:      
Accounts receivable 22,926 21,891  
Finished goods inventories (5,634) 55,321  
Prepaid expenses and other assets 14,923 (717,808)  
Accounts payable and other liabilities (64,450) 605,350  
Net cash (used in) provided by operating activities (14,302) 37,023  
Cash flows from investing activities:      
Capital expenditures (8,068) (9,371)  
Net cash used in investing activities (8,068) (9,371)  
Cash flows from financing activities:      
Proceeds from senior notes due 2027 0 500,000  
Payment of senior notes due 2021 0 (400,000)  
Premiums paid to extinguish debt 0 (5,252)  
Payment of debt issuance costs 0 (5,722)  
Borrowings under secured revolving credit facility 644,000 70,000  
Payments on secured revolving credit facility 0 (135,000)  
Repurchases of common stock (45,255) (39,966)  
Dividends paid (26,260) (22,756)  
Withholdings from vestings of restricted stock (4,712) (4,077)  
Proceeds from exercises of stock options 1,840 4,780  
Net cash provided by (used in) financing activities 569,613 (37,993)  
Net effect of exchange rate changes on cash and cash equivalents (2,454) 413  
Net increase (decrease) in cash and cash equivalents 544,789 (9,928)  
Cash and cash equivalents, beginning of period 214,311 170,077 $ 170,077
Cash and cash equivalents, end of period $ 759,100 $ 160,149 $ 214,311